Welcome to the website of the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 23 partners which will operate in Europe within the Innovative Medicines Initiative.
EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.
With a new phase of the COVID-19 pandemic, the project wishes those recovering, those still affected, and those bereaved our best for the future. Clearly, we have all been affected by this pandemic, and equally, the project too, and sadly continue to be affected, but we will aim to mitigate this as best as practicable.
EHDEN is proud to have collaborated with OHDSI colleagues in ongoing studies since March 2020 on COVID-19, see more information here and on the OHDSI website here. Meanwhile, our thanks to all who we work with in reaching our collective mission.
Our podcast series, Voice of EHDEN, has launched, listen to the trailer and episodes here.
Our 5th Data Partner call (13th October - 15th November) received 90 applications from 24 countries, more information to follow on this.
Our best wishes to all, continue to stay safe and well.
